Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Carcinoma and SLCO1B3[original query] |
---|
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients. Cancer chemotherapy and pharmacology 2011 Jun 67 (6): 1471-8. Chew Sin-Chi, Singh Onkar, Chen Xiangai, Ramasamy Rathi Devi, Kulkarni Tejal, Lee Edmund J D, Tan Eng-Huat, Lim Wan-Teck, Chowbay Balr |
Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients. British journal of clinical pharmacology 2012 Apr 73 (4): 606-18. Chew Sin Chi, Sandanaraj Edwin, Singh Onkar, Chen Xiangai, Tan Eng Huat, Lim Wan Teck, Lee Edmund J D, Chowbay Balr |
Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma. Medical oncology (Northwood, London, England) 2018 Mar 35 (4): 51. Igarashi Ryoma, Inoue Takamitsu, Fujiyama Nobuhiro, Tsuchiya Norihiko, Numakura Kazuyuki, Kagaya Hideaki, Saito Mitsuru, Narita Shintaro, Satoh Shigeru, Niioka Takenori, Miura Masatomo, Habuchi Tomono |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: